StreetAlpha.app
Home › Stocks › MLAB

Mesa Laboratories Inc (MLAB)

$127.93
▼ −4.11%
LAST CLOSE · NOV 20

Mesa makes sterilization indicators, genetic analysis instruments and lab automation systems for pharmaceutical, medical and research customers. It last closed at $127.93 on Nov 20, down 4.11% on the day. The next earnings report for MLAB is expected around Tue, Feb 2, 2027. For the quarter ended Sep 2026, MLAB reported EPS of $0.75 on revenue of $62.3M, with revenue up 2.6% from a year ago. Over its last 8 reports the stock moved an average of 9.7% the session after earnings. Over the last 12 months MLAB insiders bought $1.4M of stock on the open market and sold $1.6M, according to SEC Form 4 filings.

AI Auto Pilots
Is MLAB in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MLAB.

Key Stats

Last 12 months
Results
Revenue
$251.3M
+2.5% vs a year ago
Net income
$6.7M
2.7% margin
EPS (diluted)
$1.16
Free cash flow
$49.5M
19.7% margin
Valuation
Market cap
$719.0M
5.6M shares
P/E
110.3
Price over 12 month EPS
Price to sales
2.9
Market cap over revenue
Dividend yield
0.50%
$0.64 a share over 12 months
Balance sheet
Cash & equivalents
$22.3M
At Sep 30
Debt
$64.7M
At Sep 30
Shareholder equity
$194.6M
Shares outstanding
5.6M
At Nov 2
Fiscal year endsMarch
ExchangeNasdaq
Financials history
FY2022: $184.3M$184.3MFY2022FY2023: $219.1M$219.1MFY2023FY2024: $216.2M$216.2MFY2024FY2025: $241.0M$241.0MFY2025FY2026: $249.1M$249.1MFY2026

From MLAB's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Feb 2
Estimated date · Time not announced
Reported EPS
$0.75
Quarter ended Sep 2026
Year ago EPS
$0.45
+66.7% on a GAAP basis
Revenue
$62.3M
+2.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.31Dec '24Mar 2025: -$1.30Mar '25Jun 2025: $0.85Jun '25Sep 2025: $0.45Sep '25Dec 2025: $0.65Dec '25Mar 2026: -$0.74Mar '26Jun 2026: $0.49Jun '26Sep 2026: $0.75Sep '26Latest $0.75
Revenue by quarter
Dec 2024: $62.8MDec '24Mar 2025: $62.1MMar '25Jun 2025: $59.5MJun '25Sep 2025: $60.7MSep '25Dec 2025: $65.1MDec '25Mar 2026: $63.7MMar '26Jun 2026: $60.1MJun '26Sep 2026: $62.3MSep '26Latest $62.3M
How MLAB moved after its last 8 reports
Average move the session after a report ±9.7%
Nov 9, 2026After the close+7.1%
Aug 10, 2026After the close+9.5%
May 27, 2026Time not announced−14.5%
Feb 3, 2026Time not announced+8.7%
Nov 6, 2025After the close+1.5%
Aug 5, 2025Time not announced−24.9%
May 28, 2025Time not announced−8.9%
Feb 4, 2025Time not announced+2.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on MLABStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on MLAB
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on MLAB

Technical Analysis

MLAB · as of the Nov 20 close · updated each morning
Moving sideways

The stock is 2% below its 20 day and 2% below its 50 day average. It is 16% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 47). The nearest support is the swing low (Oct 8) at $125.13, and the nearest resistance the Pivot at $129.55.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 4.7%/day
Key levels
$144.3552 week high+12.8%
$132.70Swing high (Sep 3)+3.7%
$132.38Pivot R1+3.5%
$130.9220 day average+2.3%
$130.0450 day average+1.6%
$129.55Pivot+1.3%
$127.93Last close
$125.13Swing low (Oct 8)−2.2%
$125.11Pivot S1−2.2%
$119.64100 day average−6.5%
$107.68200 day average−15.8%
$70.1952 week low−45.1%
Indicators
RSI (14)46.74Middle of its rangeNeutral
MACD1.56Below its signal lineBearish
Stochastic60.2Middle of its rangeNeutral
ADX (14)13.5No clear trend
Williams %R-60.3Oversold below −80, overbought above −20Neutral
CCI (20)-28.5Oversold below −100, overbought above 100Neutral
Rate of change−0.3%Change over 10 sessionsBearish
ATR (14)$6.02Typical daily range, 4.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for MLAB

What happened before

See how MLAB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow MLAB usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How MLAB has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for MLABHow many large options trades hit MLAB, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

MLAB Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●87 buying vs 78 selling
  • ▲Held by funds +9.9 pts
  • ▲Funds holding +25
  • ▼Superinvestors: 0 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding184159+15.7%
In funds' top 10110.0%
Held by funds99.4%89.5%+9.9 pts
New / increased43 / 4419 / 72−4.4%
Reduced / sold out58 / 2038 / 18+39.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MLAB institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

MLAB Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$1.4M5 buys · 4 insiders
Sold$1.6M7 sales · 4 insiders
16% of the selling was under pre-arranged trading plans.
Cluster buy: 2 insiders bought $902K between Aug 13 and Aug 13.
2026-03 bought $452K2026-06 sold $770K2026-08 bought $902K2026-08 sold $800KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 13R Tony TripenyDirectorBuy900$113.69$102K
Aug 13Siddhartha KadiaPresident and CEOBuy7,093$112.80$800K
Aug 13John James SullivanDirectorSale7,093$112.80$800K
Jun 22John SakysCFOSale2,827$89.50$253K
Jun 22Brian David ArchboldSVP OperationsSale2,516$89.50$225K
Jun 22Lyndsey Elizabeth CrennenCaoSale442$89.50$40K
Every insider buy and sale for MLAB over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See MLAB insider trades →

From SEC Form 4 filings by MLAB's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MLAB is in one of them and how their past MLAB trades turned out.

MLAB in the AI portfolios
Loading…

MLAB News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MLAB in an article yet. Here's the latest on the wider market.

MLAB in the news

About Mesa Laboratories

Mesa is based in Lakewood, Colorado, and designs and makes life sciences tools and quality control products for regulated industries. Its sterilization indicators test whether sterilization and cleaning processes work, and it sells them to dental offices, hospitals, and pharmaceutical and medical device makers. The company also makes genetic analysis instruments for clinical research labs, automated systems for protein analysis and peptide synthesis used by biopharmaceutical companies, and calibration and testing services.

Headquarters
Lakewood, CO